December 13, 2019
Nihon Generic and Fuso Pharmaceutical Industries listed their generic versions of Bayer’s hyperphosphatemia drug Fosrenol OD (lanthanum carbonate) on December 13 after winning a patent suit brought on by the German originator. Their launches are expected for early next year...read more